DESFERRIOXAMINE (DFO) INFUSION TEST MAY PREDICT BONE ALUMINUM (AL) DEPOSITS IN HEMODIALYZED (HD) PATIENTS

被引：0
|
作者：
BERLAND, Y
CHARHON, S
GRANVUILLEMIN, M
OLMER, M
机构：
[1] HOP CONCEPTION,SERV NEPHROL,F-13385 MARSEILLE 4,FRANCE
[2] INSERM,U234,F-69008 LYON,FRANCE
来源：
KIDNEY INTERNATIONAL | 1984年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：539 / 539
页数：1
相关论文
共 36 条
  • [21] VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS
    DHAESE, PC
    COUTTENYE, MM
    LAMBERTS, LV
    GOODMAN, WG
    NUYTS, GD
    LEMONIATOU, E
    DIGENIS, P
    SOTORNIK, I
    FAGALDE, A
    DEBROE, ME
    KIDNEY INTERNATIONAL, 1994, 46 (05) : 1461 - 1461
  • [22] INDIRECT METHODS FOR THE DIAGNOSIS OF ALUMINUM BONE-DISEASE - PLASMA ALUMINUM, THE DESFERRIOXAMINE INFUSION TEST, AND SERUM IPTH
    NEBEKER, HG
    ANDRESS, DL
    MILLINER, DS
    OTT, SM
    ALFREY, AC
    SLATOPOLSKY, EA
    SHERRARD, DJ
    COBURN, JW
    KIDNEY INTERNATIONAL, 1986, : S96 - S99
  • [23] PARATHYROID HORMONE(PTH) RESPONSE TO CHANGES IN SERUM-CALCIUM IN PATIENTS WITH ALUMINUM (AL) BONE-DISEASE BEFORE AND AFTER DESFERRIOXAMINE (DFO) THERAPY
    MYERS, J
    RODRIGUEZ, M
    FELSENFELD, A
    LLACH, F
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 345 - 345
  • [24] DESFERRIOXAMINE TEST PREDICTS BONE ALUMINUM BURDEN IN UREMIC PATIENTS BUT NOT HISTOLOGICAL OSTEOMALACIA
    TOLANI, M
    MORINIERE, P
    VANDEVYVER, F
    FOHRER, P
    LEFLON, P
    DEFREMONT, JF
    SEBERT, JL
    LAMBREY, G
    MARIE, A
    DEBROE, M
    FOURNIER, A
    KIDNEY INTERNATIONAL, 1984, 26 (04) : 603 - 603
  • [25] THE DESFERRIOXAMINE TEST PREDICTS BONE ALUMINUM BURDEN INDUCED BY AL(OH)3 IN UREMIC PATIENTS BUT NOT MILD HISTOLOGICAL OSTEOMALACIA
    FOURNIER, A
    FOHRER, P
    LEFLON, P
    MORINIERE, P
    TOLANI, M
    LAMBREY, G
    DEMONTIS, R
    SEBERT, JL
    VANDEVYVER, F
    DEBROE, M
    PROCEEDINGS OF THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION, 1985, 21 : 371 - 376
  • [26] DOSE AND WAY OF DESFERRIOXAMINE (DFO) ADMINISTRATION IN THE TREATMENT OF ALUMINUM (AL) OVERLOAD AND IRON (FE) OVERLOAD IN DIALYSIS (D-) PATIENTS
    DEBROE, ME
    DHAESE, PC
    VERPOOTEN, GA
    LAMBERTS, LV
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 292 - 292
  • [27] COMPARATIVE-STUDY OF ALUMINUM CLEARANCE ACCORDING TO DIALYSIS TECHNIQUES AND MEMBRANES DURING HYPERALUMINEMIA TEST (HAT) BY DESFERRIOXAMINE (DFA) IN HEMODIALYZED PATIENTS
    SIMON, P
    ANG, KS
    CAM, G
    BRIGAND, A
    MAURAS, Y
    ALLAIN, P
    KIDNEY INTERNATIONAL, 1984, 25 (04) : 731 - 731
  • [28] POSSIBLE ALTERATION OF INVITRO AFFINITY OF DEFEROXAMINE (DFO) FOR IRON (FE) AND ALUMINUM (AL) IN FE OVERLOADED (FEO) HEMODIALYSIS (HD) PATIENTS
    STIVELMAN, J
    HAKIM, R
    SCHULMAN, G
    CLINICAL RESEARCH, 1987, 35 (01): : A176 - A176
  • [29] ALUMINUM REMOVAL IN UREMIC PATIENTS AFTER DESFERRIOXAMIN (DFO) INFUSION - A COMPARISON OF EFFECTIVENESS REGARDING HEMODIALYSIS (HD), HEMOFILTRATION (HF), AND CHARCOAL HEMOPERFUSION (CHP)
    WEISS, L
    DANIELSON, BG
    FELLSTROM, B
    WIKSTROM, B
    ARTIFICIAL ORGANS, 1987, 11 (04) : 336 - 336
  • [30] INFLUENCE OF ALUMINUM (AL) TOXICITY AND HYPERPARATHYROIDISM ON BONE-SCINTIGRAPHY IN HEMODIALYSIS (HD) PATIENTS
    TIELEMANS, C
    DRATWA, M
    WENS, R
    COLLART, F
    SMEYERS, J
    VERBEELEN, D
    TRACE ELEMENTS IN MEDICINE, 1985, 2 (03): : 133 - 133
1234